Capstone Investment Advisors LLC Purchases Shares of 26,904 Enovix Co. (NASDAQ:ENVX)

Capstone Investment Advisors LLC purchased a new stake in shares of Enovix Co. (NASDAQ:ENVXFree Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 26,904 shares of the company’s stock, valued at approximately $216,000.

A number of other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its position in Enovix by 4.1% during the fourth quarter. Vanguard Group Inc. now owns 12,928,993 shares of the company’s stock valued at $161,871,000 after acquiring an additional 513,508 shares during the last quarter. Electron Capital Partners LLC boosted its position in Enovix by 20.0% during the fourth quarter. Electron Capital Partners LLC now owns 3,239,296 shares of the company’s stock valued at $40,556,000 after acquiring an additional 540,399 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Enovix by 2,228.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,438,011 shares of the company’s stock valued at $11,518,000 after acquiring an additional 1,376,253 shares during the last quarter. Masters Capital Management LLC boosted its position in shares of Enovix by 18.2% during the 4th quarter. Masters Capital Management LLC now owns 1,300,000 shares of the company’s stock worth $16,276,000 after purchasing an additional 200,000 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Enovix by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,089,959 shares of the company’s stock worth $13,646,000 after purchasing an additional 55,157 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.

Insider Buying and Selling at Enovix

In other Enovix news, Director Gregory Reichow sold 7,500 shares of the stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $12.14, for a total value of $91,050.00. Following the completion of the sale, the director now owns 8,129 shares in the company, valued at approximately $98,686.06. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Enovix news, Director Gregory Reichow sold 7,500 shares of the stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $12.14, for a total value of $91,050.00. Following the completion of the sale, the director now owns 8,129 shares in the company, valued at approximately $98,686.06. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Ajay Marathe sold 4,954 shares of the stock in a transaction dated Sunday, April 14th. The shares were sold at an average price of $7.31, for a total transaction of $36,213.74. Following the completion of the sale, the chief operating officer now owns 978,913 shares of the company’s stock, valued at approximately $7,155,854.03. The disclosure for this sale can be found here. Company insiders own 17.30% of the company’s stock.

Analyst Upgrades and Downgrades

ENVX has been the topic of a number of research analyst reports. Cantor Fitzgerald reissued an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Thursday, April 25th. B. Riley raised shares of Enovix to a “strong-buy” rating in a research report on Tuesday, June 25th. Craig Hallum cut their price objective on shares of Enovix from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $12.00 and set an “overweight” rating on the stock in a research report on Friday, April 26th. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $17.00 price objective on shares of Enovix in a research report on Thursday, June 27th. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $18.33.

View Our Latest Report on ENVX

Enovix Trading Up 1.6 %

ENVX opened at $17.50 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 4.89 and a quick ratio of 4.77. Enovix Co. has a fifty-two week low of $5.70 and a fifty-two week high of $23.90. The firm has a market capitalization of $2.98 billion, a PE ratio of -13.06 and a beta of 2.04. The company’s 50-day moving average is $11.90 and its 200 day moving average is $10.25.

Enovix (NASDAQ:ENVXGet Free Report) last posted its earnings results on Wednesday, May 1st. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.05). The business had revenue of $5.27 million during the quarter, compared to analyst estimates of $4.16 million. Enovix had a negative return on equity of 85.47% and a negative net margin of 1,448.90%. As a group, research analysts predict that Enovix Co. will post -1.15 earnings per share for the current fiscal year.

Enovix Company Profile

(Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.